Keenova Therapeutics plc
CIK:
0001567892
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filer
State of Incorporation
Ireland
Country
Ireland
Business Address
COLLEGE BUSINESS & TECHNOLOGY PARK, DUBLIN 15, , D15
Mailing Address
COLLEGE BUSINESS & TECHNOLOGY PARK, DUBLIN 15, , D15
Phone
353 1 6960000
Fiscal Year End
1231
EIN
981088325
Financial Overview
FY2024
$2.57B
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
Insider Trading
STRONG BUY
1 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN
Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB
Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA
Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN
Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.